Clinical trial
Bleomycin With or Without Electroporation Therapy in Treating Patients With…
NCT00006035 · H. Lee Moffitt Cancer Center and Research Institute, Other · Unknown status
Key facts
| NCT number | NCT00006035 |
|---|---|
| Title | Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma |
| Official title | An Open Label Lesion Controlled Study of Electroporation Therapy (EPT) for the Treatment of Cutaneous Metastatic Melanoma Using the Genetronics, Inc. Medpulser System and Bleomycin |
| Lead sponsor | H. Lee Moffitt Cancer Center and Research Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Biological, Drug |
| Interventions | bleomycin sulfate, electroporation therapy |
| Start date | Jun 1, 2000 |
| First posted | Jun 21, 2004 |
| Last update posted | Sep 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: